MEDIPHARM Aktie

>MEDIPHARM Aktienkurs

0.037 EUR -11.9% (TradegateBSX)

Ask: 0.045 EUR / 22400 Stück

Bid: 0.04 EUR / 25400 Stück

Tagesumsatz: 215 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

MEDIPHARM Aktie über LYNX handeln

Intraday

1 Jahr

>MEDIPHARM Performance

1 Woche: -12,3%

1 Monat: -10,2%

3 Monate: -11,9%

6 Monate: -21,8%

1 Jahr: -38,7%

laufendes Jahr: -14,7%

>MEDIPHARM Aktie

Name:

MEDIPHARM LABS CORP.

Land:

Kanada

Sektor:

Gesundheit

ISIN/ Wkn:

CA58504D1006 / A2N7AA

Symbol/ Ticker:

MLZ (Frankfurt)

Kürzel:

FRA:MLZ, ETR:MLZ, MLZ:GR

Index:

Webseite:

https://www.medipharmlabs..

Profil:

MediPharm Labs Corp. is a specialized pharmaceutical company engaged in the production of cannabis-derived pharmaceutical products. The company focuses on the extraction, purification, and production of cannabinoid-based health products, utilizing ad..
>Volltext..

Marktkapitalisierung:

17.02 Mio. EUR

Unternehmenswert:

10.81 Mio. EUR

Umsatz:

28.68 Mio. EUR

EBITDA:

-4.4 Mio. EUR

Nettogewinn:

-4.99 Mio. EUR

Gewinn je Aktie:

-0.01 EUR

Schulden:

0.26 Mio. EUR

Liquide Mittel:

6.58 Mio. EUR

Operativer Cashflow:

-4.23 Mio. EUR

Bargeldquote:

1.21

Umsatzwachstum:

8.83%

Gewinnwachstum:

38.01%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

MEDIPHARM

Letzte Datenerhebung:

05.04.26

>MEDIPHARM Kennzahlen

Aktien/ Unternehmen:

Aktien: 420.76 Mio. St.

Frei handelbar: 90.62%

Leerverk. Aktien: -

Rückkaufquote: -0.05%

Mitarbeiter: 161

Umsatz/Mitarb.: 0.16 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: -

Bewertung:

KGV: -

KGV lG: -

KUV: 0.59

KBV: 0.84

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: 28.23%

Gewinnmarge: -17.41%

Operative Marge: -19.3%

Managementeffizenz:

Gesamtkaprendite: -15.67%

Eigenkaprendite: -19.36%

>MEDIPHARM Peer Group

Gesundheit, Cannabis- Produkte

>MEDIPHARM Chart & Kurs - Tradegate

>MEDIPHARM News

30.03.26 - 16:48	Zusammenfassung des Earnings Call: MediPharm Labs verfehlt Umsatzprognose für Q4 2025, überzeugt aber mit strategischer Ausrichtung (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

30.03.26 - 14:12	MediPharm Labs reports Q4 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

30.03.26 - 13:48	MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue (GlobeNewswire EN)
	MediPharm Labs, today announced its financial results for the full year and three months ended December 31st, 2025....

26.03.26 - 00:09	MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results (GlobeNewswire EN)
	MediPharm Labs will release its financial results for the three & twelve months ended December 31st, 2025, before markets open on Monday, March 30th, 2026....

19.01.26 - 14:15	MediPharm Labs appoints Greg Hunter as interim CEO (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

19.01.26 - 14:03	MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO (GlobeNewswire EN)
	MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO...

19.12.25 - 14:48	Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company′s Suite of Licenses and Proven U.S. Clinical Trial Supply Experience (GlobeNewswire EN)
	Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs...

11.12.25 - 02:33	MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns (GlobeNewswire EN)
	MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns...

04.12.25 - 14:45	MediPharm Labs Completes First Shipment to France (GlobeNewswire EN)
	MediPharm Labs is pleased to announce the completion of the Company's first shipment to France....

14.11.25 - 16:03

MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law (GlobeNewswire EN)

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that the Superior Court of Justice – Ontario (Commercial List) (the “Court”) has fully dismissed the statement of claim (CV-25-00742450-0000) (the “Claim”) issued by Apollo Technology Capital Corporation (“Apollo”), Nobul Technologies Inc. (“Nobul”), and Regan McGee (together with Apollo and Nobul, the “Plaintiffs”) on May 5, 2025, against MediPharm's Chief Executive Officer, David Pidduck, and Chairman of the Board, Chris Taves....

13.11.25 - 15:51	MediPharm Labs reports Q3 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.11.25 - 14:03	MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains (GlobeNewswire EN)
	MediPharm delivered another successful quarter of strong year-over-year revenue growth in the three months ended September 30, 2025 ("Q3 2025")....

11.11.25 - 00:03	MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results (GlobeNewswire EN)
	MediPharm will release its third quarter financial results before markets open on Thursday, November 13th, 2025....

07.11.25 - 22:30	MediPharm Labs Raises Concerns About Poorly Qualified Dissident Nominees (PR Newswire)
	TORONTO, May 15, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, today provided its shareholders with additional information about the six nominees for its board of directors (the......

07.11.25 - 22:24	MediPharm Labs Files Proxy Materials, Issues Chair′s Letter to Shareholders (PR Newswire)
	TORONTO, May 13, 2025 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, has filed its Management Information Circular ("MIC" or the "Circular") and proxy materials (the "Meeting Materials")......

14.08.25 - 14:42	MediPharm Labs reports Q2 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.08.25 - 13:33	MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis (GlobeNewswire EN)
	MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis....

13.08.25 - 13:33	MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States (PR Newswire)
	MediPharm Labs holds unique US Food and Drug Administration (FDA) site registration in relation to the manufacturing and release of pharmaceutical cannabis products. MediPharm is the only US FDA Audited purpose-built commercial cannabis facility in Canada. One of a handful globally. The......

11.08.25 - 13:39	MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results (GlobeNewswire EN)
	MediPharm announces it will release its second quarter 2025 financial results before markets open on Thursday, August 14th, 2025....

24.07.25 - 13:03	MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler (GlobeNewswire EN)
	MediPharm Labs Launches New Shake & Puff CBN THC Nighttime Metered Dose Inhaler in Canada....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram